Results 181 to 190 of about 110,182 (337)

Synergistic Efficacy of Chidamide and LB100 in Sézary Syndrome via TNC Downregulation and PI3K/AKT/mTOR Dephosphorylation

open access: yesCancer Science, EarlyView.
Chidamide combined with LB100 can effectively promote the death of Sézary Syndrome by inhibiting the expression of TNC and the phosphorylation of PI3K/AKT/mTOR. ABSTRACT Primary cutaneous T‐cell lymphoma (CTCL) manifests as a distinct variant of T‐cell non‐Hodgkin's lymphoma, predominantly impacting skin tissues and constituting approximately 75%–80 ...
Nan Chen   +7 more
wiley   +1 more source

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements

open access: yesJAAD Case Reports
Gabriela Piñero-Crespo, BS   +7 more
doaj   +1 more source

Feline cutaneous lymphoma: an evaluation of disease presentation and factors affecting response to treatment. [PDF]

open access: yesJ Feline Med Surg, 2022
Siewert J   +5 more
europepmc   +1 more source

Cutaneous epitheliotropic lymphoma in a ferret [PDF]

open access: bronze, 1996
Michele Rosenbaum   +3 more
openalex   +1 more source

New Topical and Systemic Treatments for Atopic Dermatitis

open access: yesClinical &Experimental Allergy, EarlyView.
This review summarises new topical and systemic treatments for atopic dermatitis, their relative effectiveness, and important safety data. ABSTRACT Atopic dermatitis is an inflammatory skin condition characterised by pruritus and a chronic relapsing–remitting course.
Sara Mirali, Aaron M. Drucker
wiley   +1 more source

p53 and bcl‐2 expression do not correlate with prognosis in primary cutaneous large T‐cell lymphomas [PDF]

open access: green, 1997
C.W. van Haselen   +6 more
openalex   +1 more source

Too Much and Too Little Medicine Are Two Sides of the Same Coin

open access: yes
Australasian Journal of Dermatology, EarlyView.
Eugene Tan
wiley   +1 more source

Home - About - Disclaimer - Privacy